about
Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.The sodium-activated potassium channel Slack is required for optimal cognitive flexibility in miceNormal Performance of Fmr1 Mice on a Touchscreen Delayed Nonmatching to Position Working Memory TaskIn vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndromeCGG repeat in the FMR1 gene: size mattersA mouse model of the human Fragile X syndrome I304N mutation.The cyclic AMP cascade is altered in the fragile X nervous systemSide effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measuresFragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administrationFragile X and autism: Intertwined at the molecular level leading to targeted treatments.Increasing our understanding of human cognition through the study of Fragile X Syndrome.Mouse behavioral assays relevant to the symptoms of autism.Epigenetic regulation of neuronal dendrite and dendritic spine developmentDiscrimination learning and attentional set formation in a mouse model of Fragile X.Functional and structural deficits at accumbens synapses in a mouse model of Fragile X.Activity-dependent FMRP requirements in development of the neural circuitry of learning and memory.Nxf7 deficiency impairs social exploration and spatio-cognitive abilities as well as hippocampal synaptic plasticity in mice.Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice.Group I mGluR antagonist rescues the deficit of D1-induced LTP in a mouse model of fragile X syndrome.Craniofacial characteristics of fragile X syndrome in mouse and man.Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models.Visual-spatial learning impairments are associated with hippocampal PSD-95 protein dysregulation in a mouse model of fragile X syndromeGlycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.Potential pharmacological treatment of fragile X syndrome during adulthood.Effect of genetic background on acoustic startle response in fragile X knockout mice.Protein expression profiling of the drosophila fragile X mutant brain reveals up-regulation of monoamine synthesis.Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice.Forebrain-specific, conditional silencing of Staufen2 alters synaptic plasticity, learning, and memory in rats.Negative Effects of Chronic Rapamycin Treatment on Behavior in a Mouse Model of Fragile X Syndrome.Deficits in the activity of presynaptic γ-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome.FVB.129P2-Pde6b(+) Tyr(c-ch)/Ant, a sighted variant of the FVB/N mouse strain suitable for behavioral analysis.Increased coupling of caveolin-1 and estrogen receptor α contributes to the fragile X syndrome.Utility of the Hebb-Williams Maze Paradigm for Translational Research in Fragile X Syndrome: A Direct Comparison of Mice and Humans.Fragile X syndrome: From protein function to therapy.Fragile X syndrome
P2860
Q27303466-DC584381-6083-4341-8449-9ACEB8B958FFQ27321420-123FF09A-BA20-4124-8C0C-A05F6C68F375Q30387508-DAD981CC-0388-4BCC-8320-067A57F406ECQ30406616-1CDB8DCE-953B-4958-969B-2D2FAC5F63E5Q30464036-4D6A3E19-5B11-4274-BFCB-1766FC1B6181Q30484632-8C355CD9-4B45-4E37-933A-9AC6DB693C43Q33300336-0D4D666E-B31A-42B7-B7A8-7A5DF6CBC309Q33650170-D497DF19-FEF7-4573-9810-44B7CBB0E953Q33738812-D02618FC-642B-4C48-A2FC-759C86932FB3Q34198650-7B3EF7E3-C93B-49C3-B383-50D9E7E10792Q34435526-222C2C7E-51D3-43EC-B6E0-656EEE772011Q34699041-D496D743-E8DF-43A3-9BF1-8C89E3419707Q35018423-7E430F00-1D19-4594-9092-CAF99D6440DBQ35027861-24C80A2F-AFE6-4505-8D4A-CCFF49415B31Q35218838-C69DA8AC-37E8-4E46-8E5C-EFC6A0415AD9Q35228888-17A80951-B184-4EB5-8C87-40F3FB10E398Q35837309-2938B300-3FDA-4D18-92C3-8882D835E539Q35844502-89BF37F8-14F1-4A86-A71D-C54B33CDCED9Q36305963-8B88E1B6-F68D-41F0-9BE5-C44701B6202EQ37043811-C59D64BE-933A-4CBE-BFCA-55221916E310Q37564195-5B8CF4C1-92CF-49E6-9F29-B4867A8D9472Q37585628-36FB4A9A-0287-4AA3-AEA4-5481CCAD93CBQ38126701-76BB1DE2-B4CF-4A3E-83C9-1CC7B73B0623Q40295553-7808A91C-7A31-4B32-A43D-33F16CB5AEB9Q41351985-A8887EF7-F723-4A0A-A8E8-A8AC3546F77DQ44113731-A872A13D-8BDA-472E-9955-CC3FE91DC5C6Q45213302-F4C5CEEB-5970-4CCE-BF38-7C185DD701FAQ46185789-60B0D042-37C9-435B-8A31-DEC4CFC02579Q47390859-979CFC5D-BFC3-49DB-8D93-BA1DE24D8AA4Q47551363-5F191A2B-44BF-43FD-8ADA-37D481968051Q47796729-88B91962-3E3C-4D42-B357-B552DD8FE64CQ48379531-A04AFAC2-9775-4563-9B72-C7430AF11E4EQ50600460-38C9FE13-9111-4A61-B60D-940BFB21AE92Q52592966-367B8D07-EFBD-4BB3-8E2D-E437E95D8BFFQ54782597-3C732138-61A0-4419-9096-BC022038E81CQ57828399-1C69637C-A3FB-4829-9BD4-2530E6D7AD58
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Of mice and the fragile X syndrome.
@ast
Of mice and the fragile X syndrome.
@en
type
label
Of mice and the fragile X syndrome.
@ast
Of mice and the fragile X syndrome.
@en
prefLabel
Of mice and the fragile X syndrome.
@ast
Of mice and the fragile X syndrome.
@en
P1433
P1476
Of mice and the fragile X syndrome
@en
P2093
R Frank Kooy
P304
P356
10.1016/S0168-9525(03)00017-9
P50
P577
2003-03-01T00:00:00Z